RegisterLogin

BIIB022

CAT: 0804-HY-P991253Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-P991253Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
BIIB022 is a human IgG4 monoclonal antibody (mAb) targeting IGF1R/CD221. BIIB022 blocks IGF-1 and IGF-2-induced phosphorylation of IGF-1R and downstream substrates. BIIB022 can be used in lung, pancreatic, and colon cancer research. Recommended isotype control: Human IgG4 kappa, Isotype Control (HY-P99003) [1].
UNSPSC
12352203
Target
IGF-1R
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
References & Citations
[1]von Mehren M, et al. A phase 1, open-label, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in subjects with relapsed or refractory solid tumors. Invest New Drugs. 2014 Jun;32 (3) :518-25.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Related Products

CatalogName
HY-103537ABIIB042
HY-P991439BIIB023
HY-10212-01BIIB021
HY-103537(Rac) -BIIB042
HY-10212R-01BIIB021 (Standard)
HY-10212ABIIB021 (mesylate)
HY-P991376BIIB076
HY-P991433BIIB036
HY-139984-01BIIB091
HY-131342-01BIIB068

Alternative Products

CatalogName
T9901A-1649-01BIIB022
MBS1580972-01Research Grade Anti-Human CD221/IGF1R (BIIB022)
A136401Anti-CD221/IGF1R (BIIB022) Biosimilar (Monoclonal, IgG)

Popular Products